Jianpi Huayu Decoction enhances the effect of sorafenib and alleviates adverse events in hepatocellular carcinoma by remodeling the gut microbiota

• Main Authors: Xue Deng (Author), Yingjie Xie (Author), Yantong Lu (Author), Xueyan Li (Author), Xuan Guo (Author), Xuhui Huang (Author), Xiaohe Lan (Author), Juze Lin (Author), Wei Tan (Author), Changjun Wang (Author)
• Format: Book
• Published: Elsevier, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: There is an urgent need for effective treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multi-kinase inhibitor, is the first-line treatment for advanced HCC, which has a modest efficacy due to severe adverse effects (AEs), acquired resistance, and others. Jianpi Huayu D...